RE:RE:February 2 press release states FS on February 12 andI am not sure we are going to get any more information or updates with financials other than the company is disappointed with FDA decision. That seems to be there response to all issues. They have never been concerned with shareholder value, so I don't see them starting now. They probably had offers to sell the company earlier but chose not to sell, they gambled and lost and we are all suffering for it. Not sure what a phase 3 company is worth needing to complete another trial. Likely lost most of there bargaining power with FDA response, so we are screwed for a long time.